Studies how exercise responds in adults with obesity
Looks at how inflammation affects muscle and exercise response in adults with obesity.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Exercise Response in Humans With Obesity
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 22 Sept 2023
- Expected to end
- Jul 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- Treadmill Test
- Strength Test
- Dual-Energy X-Ray Absorptiometry
- Muscle Biopsy
- Fat Biopsy
- Resting Energy Expenditure
- Magnetic resonance imaging
- Record updated
- 11 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men and women aged 20 to 45 who have obesity. It studies how long-lasting inflammation affects muscle function and the body's response to exercise.
- Age
- 20 to 45 years
- Sex
- Men and women
- Disease stage
- Obesity
Main reasons for not taking part
- Diabetes or fasting plasma glucose >126 mg/dL (7 mmol/L)
- Anemia (hemoglobin <11 g/dl in women, <12 g/dl in men)
- Active coronary artery disease or unstable macrovascular disease
- Renal failure (serum creatinine > 1.5mg/dl (133 µmol/L))
- Smoking, pregnancy or breastfeeding
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Obese men and women ≥ 20 and ≤ 45 years of age
Who cannot take part
- Active coronary artery disease or history of unstable macrovascular disease (unstable angina, myocardial infarction, stroke, and revascularization of coronary, peripheral or carotid artery within 3 months of recruitment)
- Oral warfarin group medications or history of blood clotting disorders
- Debilitating chronic disease (at the discretion of the investigators)
- Diabetes or fasting plasma glucose >126 mg/dL
- Anemia (female subjects hemoglobin of <11 g/dl and male subjects hemoglobin <12 g/dl)
- Renal failure (serum creatinine > 1.5mg/dl)
- Chronic active liver disease defined as aspartate aminotransferase (AST)>144 IU/L or alanine transaminase (ALT) >165 IU/L)
- Smoking
- Pregnancy or breastfeeding
- Alcohol consumption greater than 2 glasses/day or other substance abuse
- Untreated or uncontrolled hypothyroidism
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 45 years old?
Where in United States
- Mayo Clinic in RochesterRochester, United StatesContact: Rachel OslandTaking people
About the trial
What the trial wants to find out
This study is being done to understand how chronic inflammation affects muscle function and responses to exercise.
The 2 groups in the trial
- Lean Group
Participants with body mass index 20-25 kg/m\^2 will complete an outpatient study visit (body composition, blood draw, treadmill test, strength test) and an inpatient visit (muscle biopsies, fat biopsies, indirect calorimetry, exercise test).
Treatment: Treadmill Test, Strength Test, Dual-Energy X-Ray Absorptiometry, Muscle Biopsy, Fat Biopsy, Resting Energy Expenditure, and Magnetic resonance imaging
- Obese Group
Participants with body mass index 30-45 kg/m\^2 will complete an outpatient study visit (body composition, blood draw, treadmill test, strength test) and an inpatient visit (muscle biopsies, fat biopsies, indirect calorimetry, exercise test).
Treatment: Treadmill Test, Strength Test, Dual-Energy X-Ray Absorptiometry, Muscle Biopsy, Fat Biopsy, Resting Energy Expenditure, and Magnetic resonance imaging
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Exercise Response in Humans With Obesity
- Plain-language title
- Studies how exercise responds in adults with obesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05857150, who can take part
- Record updated
- 11 September 2026